Pathological complete response in advanced intrahepatic cholangiocarcinoma was achieved through tri-modal therapy: A case report and review of literature

Figure 3  Serial carbohydrate antigen 19-9 monitoring during treatment shows that carbohydrate antigen 19-9 decreased significantly after two cycles of combined therapy, returned to the normal range after three cycles, and remained within the normal range during postoperative follow-up.